Reset
Showing 2 of 2 academic articles

Preclinical ex-vivo Testing of Anti-inflammatory Drugs in a Bovine Intervertebral Degenerative Disc Model

Zhen Li, Yannik Gehlen, Yannik Gehlen, Fabian Heizmann et al. • Frontiers in Bioengineering and Biotechnology (2020)

Discogenic low back pain (LBP) is a main cause of disability and inflammation is presumed to be a major driver of symptomatic intervertebral disc degeneration (IDD). Anti-inflammatory agents are currently under investigation as they demonst...

DOAJ Open Access (DOAJ) DOI: 10.3389/fbioe.2020.00583

Case Report: A severe case of immunosuppressant-refractory immune checkpoint inhibitor-mediated colitis rescued by tofacitinib

Mark W. D. Sweep, Mark W. D. Sweep, Martijn J. H. Tjan, Mark A. J. Gorris et al. • Frontiers in Immunology (2023)

Immune checkpoint inhibitor therapy for cancer treatment can give rise to a variety of adverse events. Here we report a male patient with metastatic melanoma who experienced life-threatening colitis and duodenitis following treatment with i...

DOAJ Open Access (DOAJ) DOI: 10.3389/fimmu.2023.1212432